Jacmar: There are several variables that would det
Post# of 30028
1) LymPro Revenue to start January 2015.
2) We up list in December of 2014.
3) We started the RS and Up List process at .25 cents.
Under these conditions, I would feel emboldened because we would be so undervalued.....right as LymPro starts bringing in revenue and right before we get the MANF orphans.
If we already had spiked up to .60 cents before we RS and up list, I would be more cautious, thinking we could slide back some.